[1]何阶德,梁 航,黄 朦,等.血清C肽、自噬关键分子酵母Atg6同系物、纤维胶凝蛋白3在2型糖尿病肾病患者中的表达变化及其预测价值研究[J].陕西医学杂志,2024,(3):327-330.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.008]
　HE Jiede,LIANG Hang,HUANG Meng,et al.Changes and predictive value of serum C peptide,ATG6 autophagy related 6 homolog and Ficolin-3 in type 2 diabetic nephropathy[J].,2024,(3):327-330.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.008]
点击复制

血清C肽、自噬关键分子酵母Atg6同系物、纤维胶凝蛋白3在2型糖尿病肾病患者中的表达变化及其预测价值研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年3期
页码:
327-330
栏目:
临床研究
出版日期:
2024-03-05

文章信息/Info

Title:
Changes and predictive value of serum C peptide,ATG6 autophagy related 6 homolog and Ficolin-3 in type 2 diabetic nephropathy
作者:
何阶德1; 梁 航1; 黄 朦1; 邓洪浩2; 刘红玉3
(1.湘南学院附属医院肾内科,湖南 郴州 421800; 2.湘南学院附属医院内分泌科,湖南 郴州 421800; 3.湘南学院附属医院全科医学科,湖南 郴州 421800)
Author(s):
HE Jiede; LIANG Hang; HUANG Meng; DENG Honghao; LIU Hongyu
(Department of Nephrology,Affiliated Hospital of Xiangnan University,Chenzhou 421800,China)
关键词:
2型糖尿病肾病;  血清C肽;  自噬关键分子酵母 Atg6 同系物;  纤维胶凝蛋白3;  肾功能;  预测价值
Keywords:
Type 2 diabetic nephropathy;  Serum C peptide;  ATG6 autophagy related 6 homolog;  Ficolin-3;  Renal function;  Predicted value
分类号:
R 587.2
DOI:
DOI:10.3969/j.issn.1000-7377.2024.03.008
文献标志码:
A
摘要:
目的:探讨血清C肽、自噬关键分子酵母 Atg6 同系物(Beclin1)、纤维胶凝蛋白3(Ficolin-3)在2型糖尿病肾病(DN)患者中的表达变化及其预测价值。方法:选取2型糖尿病(T2DM)患者135例,其中单纯T2DM患者73例(T2DM组),DN患者62例(DN组),并选取同期体检健康者60例为对照组。比较三组肾功能及血清C肽、Beclin1、Ficolin-3水平。分析肾功能与C肽、Beclin1、Ficolin-3的关系,以及血清C肽、Beclin1、Ficolin-3对DN的预测价值。结果:DN组Scr、BUN高于T2DM组和对照组,且T2DM组高于对照组(均P<0.05)。DN组eGFR低于T2DM组和对照组,且T2DM组低于对照组(均P<0.05)。DN组血清C肽水平高于T2DM组和对照组,且T2DM组高于对照组(均P<0.05)。DN组血清Beclin1、Ficolin-3水平低于T2DM组和对照组,且T2DM组低于对照组(均P<0.05)。血清C肽水平与Scr、BUN呈正相关,与eGFR呈负相关(均P<0.05)。血清Beclin1、Ficolin-3水平与Scr、BUN呈负相关,与eGFR呈正相关(均P<0.05)。血清C肽、Beclin1、Ficolin-3对DN均有一定的预测价值,三者联合的预测价值更高。结论:2型DN患者血清C肽水平升高,Beclin1、Ficolin-3水平降低,三者联合具有较高的预测价值。
Abstract:
Objective:To investigate the changes and predictive value of serum C peptide,ATG6 autophagy related 6 homolog(Beclin1)and Ficolin-3 in type 2 diabetic nephropathy(DN).Methods:A total of 135 patients with type 2 diabetes mellitus(T2DM)were selected,including 73 patients with T2DM alone(T2DM group),62 patients with DN(DN group),and 60 healthy subjects in the same period were selected as the control group.Renal function and serum levels of C-peptide,Beclin1 and Ficolin-3 were compared among the three groups.The relationship between renal function and C-peptide,Beclin1 and Ficolin-3,and the predictive value of serum C-peptide,Beclin1 and Ficolin-3 on DN were analyzed.Results:DN group had higher Scr and BUN than other groups,and T2DM group had higher Scr and BUN than control group(all P<0.05).The eGFR in DN group was lower than that in T2DM group and control group,and T2DM group was lower than control group(all P<0.05).The serum C peptide level of DN group was higher than that of T2DM group and control group,and T2DM group was higher than control group(all P<0.05).Serum Beclin1 and Ficolin-3 levels in DN group were lower than those in T2DM group and control group,and those in T2DM group were lower than those in control group(all P<0.05).Serum C peptide level was positively correlated with Scr and BUN,and negatively correlated with eGFR(all P<0.05).Serum Beclin1 and Ficolin-3 levels were negatively correlated with Scr and BUN,but positively correlated with eGFR(all P<0.05).Serum C peptide,Beclin1 and Ficolin-3 all had certain predictive value for DN,and the combined value of the three was higher.Conclusion:The level of serum C peptide increases in patients with type 2 DN,while the levels of Beclin1 and Ficolin-3 decrease,and the combination of the three has a higher predictive value.

参考文献/References:

[1] 贾艳燕,刘婷,方敬爱,等.糖尿病肾病患者血清Beclin1、ATG7与蛋白尿相关性研究[J].中国中西医结合肾病杂志,2022,23(3):228-230.
[2] WANG D,DU Y,HUANG R,et al.Bioinformatic analysis of CHEK1 as a marker of glomerular epithelial cell injury in diabetic nephropathy[J].Cell Mol Biol(Noisy-le-grand),2023,69(8):209-213.
[3] 肖俊锐,黄楚妮,吴石贵.血清C肽联合糖化血红蛋白检测对2型糖尿病患者的临床意义[J].深圳中西医结合杂志,2020,30(19):55-56.
[4] 高颖,王棪嫒,刘蔚,等.尿C肽浓度和尿C肽肌酐比评价空腹血清C肽水平低于检测下限的1型糖尿病患者残余β细胞功能的研究[J].中国糖尿病杂志,2023,31(3):201-204.
[5] 刘伦志,邓璐,张明霞.血管紧张素Ⅱ1型受体拮抗剂对早期糖尿病肾病患者尿液中足细胞相关蛋白nephrin、自噬基因Beclin-1mRNA排泄的影响[J].临床荟萃,2021,36(11):1005-1008.
[6] 赵能江,代春美,孙文杰,等.《中国2型糖尿病防治指南(2020年版)》糖尿病的中医药治疗部分解读[J].中华糖尿病杂志,2021,13(4):309-311.
[7] 玉山江?艾克木,哈丽达?木沙,地丽尼嘎尔.西红康联合还原型谷胱甘肽治疗2型糖尿病肾病Ⅲ期气阴两虚夹瘀证疗效及对患者微炎症状态、抗氧化的影响[J].陕西中医,2020,41(3):338-341.
[8] ALBRECHT M,STICHT C,WAGNER T,et al.The crosstalk between glomerular endothelial cells and podocytes controls their responses to metabolic stimuli in diabetic nephropathy[J].Sci Rep,2023,13(1):17985.
[9] 玉山江?艾克木,哈丽达?木沙,王晓腾,等.西红康对2型糖尿病肾病大鼠肾足细胞功能的影响[J].陕西中医,2023,44(1):16-19.
[10] 邹晨晨,郑苏,王晨彤,等.糖尿病肾病合并糖尿病周围神经病变患者血清C肽水平及其与肾功能、神经传导速度的相关性[J].广西医学,2023,45(2):138-141.
[11] 黄晓菁,郑霄,葛乔波.自噬相关分子Beclin1和LC3在糖尿病足多重耐药金黄色葡萄球菌感染中的作用[J].中国医师杂志,2021,23(6):836-841.
[12] 张爱鸣,厉钗微,高赛赛.C肽及其他因素与2型糖尿病肾病的相关性[J].浙江临床医学,2020,22(5):654-656.
[13] 肖霞,颜雪梅,李慧,等.自噬相关蛋白在1型糖尿病肾病大鼠肾脏组织内的表达及相关性初探[J].临床和实验医学杂志,2021,20(19):2032-2036.
[14] 曹洁琼,裴晓艳,胡红艳,等.血清纤维蛋白胶凝素-3水平与2型糖尿病并发周围神经病变关系的研究[J].中华全科医学,2022,20(4):570-573.
[15] 王宝君,郭翔宇,胡燕,等.2型糖尿病患者交感皮肤反应、神经传导速度与空腹血清C肽、FGF21、补体因子B水平相关性研究[J].临床和实验医学杂志,2022,21(20):2167-2170.
[16] 许凌雁,游诗瑶,宁捷.2型糖尿病患者血清Ficolin-3 ADAM10水平与颈动脉粥样硬化的关系[J].河北医学,2022,28(2):254-259.
[17] 闫妮,刘玲娇,余湘尤,等.中性粒细胞与淋巴细胞比值在2型糖尿病合并糖尿病肾病患者中的变化及检测价值研究[J].陕西医学杂志,2021,50(6):673-677.
[18] 陈玲,黄光楠.老年2型糖尿病患者血清25-(OH)D3与糖尿病肾病的相关性[J].临床医药文献电子杂志,2020,7(45):68-69.
[19] 张菁,姚蔚,张进安,等.沙格列汀联合前列地尔治疗老年糖尿病肾病临床评价[J].陕西医学杂志,2020,49(12):1657-1660.
[20] 孟凡飞,刘萍,杨聚豪,等.HbA1c、C肽和尿NAG对2型糖尿病早期肾损伤的诊断价值[J].检验医学,2017,32(11):1031-1035.
[21] 刘嘉鹏,冯婧,车宇娥,等.肾气丸对Zucker糖尿病肥胖大鼠肾损伤、GRP78及自噬相关因子的影响[J].北京中医药大学学报,2023,46(2):224-231.
[22] 宗扬勇.血清纤维蛋白胶凝素-3在2型糖尿病患者合并颈动脉粥样硬化中的应用价值[J].检验医学与临床,2021,18(6):772-776.
[23] 吴小颖,陈彤华,邢雪凤,等.HbA1c、E2、C肽对围绝经期、绝经后2型糖尿病患者合并亚临床甲状腺功能减退症的诊断价值[J].中国现代医学杂志,2023,33(1):24-31.
[24] IWAKURA H,TAKAGI T,INABA H,et al.Thyroid function,glycemic control,and diabetic nephropathy in patients with type 2 diabetes over 24 months:Prospective observational study[J].BMC Endocrine Disorders,2023,23(1):146.
[25] LIU Y,ZHAO X,YANG Z,et al.Correlation between serum C-peptide-releasing effects and the risk of elevated uric acid in type 2 diabetes mellitus[J].Endocrine Journal,2022,69(7):773-784.

备注/Memo

备注/Memo:
基金项目:湖南省科技创新计划项目(2021SK52206)
更新日期/Last Update: 2024-03-05